Prognostic factors of primary adenocarcinoma of the uterine cervix

Gynecologic Oncology

Volumn 69, Issue 2, 1998, Pages 157-164

  Chen, Ruey Jien ^a   Chang, Daw Yuan ^a   Yen, Men Luh ^a   Lee, Evelyn Fung ^a   Huang, Su Cheng ^a   Chow, Song Nan ^a   Hsieh, Chang Yao ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; UTERINE CERVIX CARCINOMA;

EID: 0032078752     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.4971     Document Type: Article

References (36)

1. Parkin D M, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 54:1993;594-606.
2. Angel C, DuBeshter B, Lin J Y. Clinical presentation and management of stage I cervical adenocarcinoma: A 25 year experience. Gynecol Oncol. 44:1992;71-78.
3. Piura B, Dgani R, Yanai-Inbar I, Cohen Y, Glezerman M. Adenocarcinoma of the uterine cervix: A study of 37 cases. J Surg Oncol. 61:1996;249-255.
4. Zreik T G, Chambers J T, Chambers S K. Parametrial involvement, regardless of nodal status: A poor prognostic factor for cervical cancer. Obstet Gynecol. 87:1996;741-746.
5. Jorgensen R G, Russo L, Mattioli L, Moore W V. Early detection of vascular dysfunction in type I diabetes. Diabetes. 37:1988;292-296.
6. Soisson A P, Soper J T, Berchuck A, Dodge R, Clarke-Pearson D. Radical hysterectomy in obese women. Obstet Gynecol. 80:1992;940-943.
7. Rutledge F N, Mitchell M F, Munsell M, Bass S, McGuffee V, Atkinson E N. Youth as a prognostic factor in carcinoma of the cervix: A matched analysis. Gynecol Oncol. 44:1992;123-130.
8. Serur E, Fruchter R G, Maiman M, McGuire J, Arrastia C D, Gibbon D. Age, substance abuse, and survival of patients with cervical carcinoma. Cancer. 75:1995;2530-2538.
9. Wilde M I, Balfour J A. Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations. Drugs. 50:1995;364-395.
10. Fujiwara H, Tortolero-Luna G, Mitchell M F, Koulos J P, Wright T C Jr. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors. Cancer. 79:1997;505-512.
11. Bhattacharya D, Redkar A, Mittra I, Sutaria U, MacRae K D. Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo. Br J Cancer. 75:1997;554-558.
12. Kucera H, Enzelsberger H, Eppel W, Weghaupt K. The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer. 60:1987;1-4.
13. Kennedy A W, Flagg J S, Webster K D. Gynecologic cancer in the very elderly. Gynecol Oncol. 32:1989;49-54.
14. Department of Health, the Executive Yuan. Reported Cancer Incidence. Health Statistics: General Health Statistics. 1988;Department of Healththe Executive Yuan. p. 49-50.
15. Diabetes. 28:1979;1039-1057.
16. Kaplan E L, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 53:1958;457-481.
17. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1966;163-170.
18. Cox D R. Regression models and life-tables. J R Stat Soc. 34:1972;187-220.
19. Saigo P E, Cain J M, Kim W S, Gaynor J J, Johnson K, Lewis J L Jr. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer. 57:1986;1584-1593.
20. Miller B E, Flax S D, Arheart K, Photopulos G. The presentation of adenocarcinoma of the uterine cervix. Cancer. 72:1993;1281-1285.
21. Schwartz S M, Weiss N S. Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol. 124:1986;1045-1047.
22. Bjorge T, Thoresen S O, Skare G B. Incidence, survival and mortality in cervical cancer in Norway, 1956-1990. Eur J Cancer. 29:1993;2291-2297.
23. Chapman G W Jr. Survival of advanced age females with cervical carcinoma. Gynecol Oncol. 46:1992;287-291.
24. Kilgore L C, Soong S J, Gore H, Shingleton H M, Hatch K D, Partridge E E. Analysis of prognostic features in adenocarcinomas of the cervix. Gynecol Oncol. 31:1988;137-148.
25. McLellan R, Dillon M B, Woodruff D, Heatley G J, Fields A L, Rosenshein N B. Long-term follow-up of Stage I cervical adenocarcinoma treated by radical surgery. Gynecol Oncol. 52:1994;253-259.
26. Hopkins M P, Schmidt R W, Roberts J A, Morley G W. The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet Gynecol. 72:1988;915-921.
27. Larson D, Copeland L, Stringer C, Gersheson D, Malone J, Edwards C. Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol. 30:1988;381-387.
28. Oka K, Nakano T, Hoshi T. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices. Cancer. 77:1996;2280-2285.
29. Gallup D G, Harper R H, Stock R J. Poor prognosis in patients with adenosquamous cell carcinoma of the cervix. Obstet Gynecol. 65:1985;416-422.
30. Eifel P J, Burke T W, Morris M, Smith T L. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol. 59:1995;38-44.
31. Shingleton H M, Bell M C, Fremgen A, Chmiel J S, Russell A H, Jones W B, Winchester D P, Clive R E. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix. Cancer. 76:1995;1948-1955.
32. Van Nagell J R Jr, Roddick J W Jr, Wallace J O. Clinical correlates of endometrial carcinoma. Am J Obstet Gynecol. 112:1972;935-937.
33. Milson I, Friberg L G. Primary adenocarcinoma of the uterine cervix. Cancer. 52:1983;942-947.
34. Jones M W, Silverberg S G. Cervical adenocarcinoma in young women: Possible relationship to microglandular hyperplasia and use of oral contraceptives. Obstet Gynecol. 73:1989;984-989.
35. Ursin G, Peters R K, Henderson B E, d'Ablaing G 3rd, Monroe K R, Pike M C. Oral contraceptive use and adenocarcinoma of cervix. Lancet. 344:1994;1390-1394.
36. Masood S, Rhatigan R M, Wilkinson E W, Barwick K W, Wilson W J. Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study. Cancer. 72:1993;511-518.